Assessing prognosis in patients with chronic lymphocytic leukemia a quarter of a century after Rai and Binet staging systems
Author:
Open Access
- 1 October 2004
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 15 (10) , 1450-1451
Abstract
Chronic lymphocytic leukemia (CLL) has an extremely heterogeneous prognosis. Nowadays, the median survival of patients with this form of leukemia is 8–10 years, compared with 5–6 years in series reported in the 1970s. This is largely due to the higher number of patients who are now being diagnosed in early phase (up to 80%) and, hence, with better prognosis [1, 2]. Individual survival, however, is highly variable.Keywords
This publication has 17 references indexed in Scilit:
- Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLLBlood, 2004
- Classical and new prognostic factors in chronic lymphocytic leukemia: Where to now?The Hematology Journal, 2002
- Genomic Aberrations and Survival in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2000
- Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic featuresBlood, 2000
- Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic LeukemiaBlood, 1999
- Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemiaLeukemia, 1999
- Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysisJournal of Molecular Medicine, 1999
- Chronic lymphocytic leukemia: a changing natural history?Leukemia, 1997
- A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysisCancer, 1981
- Clinical staging of chronic lymphocytic leukemiaBlood, 1975